Bayer
Activist-led lawsuit alleges EPA glyphosate weedkiller approval violated Endangered Species Act
EPA's interim registration approval of glyphosate in January now faces its first court challenge, as a number of food safety, ...
Viewpoint: There’s no industry conspiracy to corrupt research on bees and neonicotinoid insecticides
There’s a stereotype that industry-funded research is inherently compromised. Perhaps this is true for some specific cases, but for honey ...
Plaintiff in glyphosate-cancer trial defends original $80 million verdict against Bayer on appeal
A man who won an $80 million verdict over Monsanto Co.’s Roundup [in 2019] defended the award on appeal, including ...
EPA watchdog to determine if agency followed ‘scientifically sound principles’ in approving dicamba herbicides
The inspector general of the EPA is planning to look into whether EPA acted properly when it registered dicamba in ...
Bayer, 6 plaintiffs firms agree on draft settlement terms in Roundup-cancer litigation, but thousands of cases could still go to trial
Bayer has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging ...
Opposition to EPA re-approval of Bayer, BASF dicamba herbicides mounts as widespread crop damage continues
Decisions made in the next year will be critical for the future use of the herbicide dicamba, a weed killer ...
Judge cancels second federal glyphosate-cancer trial to aid settlement talks between Bayer, plaintiffs
In an order on [March 5], U.S. District Judge Vince Chhabria vacated the March 23 trial date for the second ...
EPA appears likely to re-approve drift-prone dicamba herbicides with added restrictions
When the U.S. EPA reregistered dicamba soybean herbicides for use on Xtend soybeans in 2018, labels were effective for two ...
Soybean damage caused by Bayer’s drift-prone dicamba herbicide spurs farmers to use competing GMO seeds, weedkillers
Bayer AG’s takeover of Monsanto has been beset by problems, and now a decades-long dominance of the $4 billion U.S ...
Bayer in ‘no rush’ to settle Roundup-cancer litigation following endorsements from EPA, Department of Justice
.... Bayer was at pains on [Feb. 27] to quell expectations it was nearing an out-of-court settlement laying to rest ...
Bayer Chairman to step down as potential $12 billion Roundup-cancer litigation settlement looms
Bayer Chairman Werner Wenning, one of the architects of a $63 billion takeover deal that has left the German crop ...
Remember the questionable study claiming glyphosate boosts cancer risk 41%? Lead author reasserts her claim, EPA refutes it, and we take a second look
Sheppard and her co-authors are intent on favoring data that appears to support the existence of a risk from glyphosate ...
$265 million dicamba weed killer verdict paves way for more successful lawsuits against Monsanto, BASF
A $265 million verdict .... against two global agribusiness giants [in late February] has now created another legal headache for ...
Bayer likely to fight new wave of Roundup-cancer litigation in Australia, despite looming US settlement
As tens of thousands of cases against the makers of the weedkiller Roundup mount up in the United States, a ...
Viewpoint: Science losing out to anti-glyphosate hysteria, farmers in a quandary as there are no alternative weedkillers as effective
Confirmation [in January] by the U.S. [EPA] that glyphosate is not carcinogenic is welcome, but .... it doesn’t matter. What ...
Weedkiller breakthrough? Bayer developing new herbicide to help farmers tackle glyphosate-resistant weeds
With stakes in the fight against tough-to-control and resistant weeds at an all-time high, Bayer is adding a new tool ...
Bayer faces ‘almost impossible’ task of ending glyphosate-cancer litigation while its Roundup herbicide remains in stores
Bayer faces an extraordinary challenge as it tries to settle tens of thousands of claims that its Roundup weedkiller causes ...
Viewpoint: ‘Dicamba Debacle’ stirs questions about the future shape of ‘industrial, intensive agriculture’
The dicamba debacle gives a chance to answer key questions about industrial agriculture with rare specificity ...
California attorney general sides with Bayer glyphosate cancer plaintiffs, challenges appeal of $78.5 million verdict
California Attorney General Xavier Becerra filed an amicus brief in Johnson v. Monsanto, arguing against preemption of state laws requiring ...
Viewpoint: Dicamba debacle trial forces a reevaluation: Was Monsanto a ‘bonafide bad actor’?
The toll on farmers is infuriating enough. But there could be widespread damage to the environment as well ...
Bayer appeals last year’s $86 million California Monsanto Roundup glyphosate-cancer trial verdict
Bayer AG has asked a California appeals court to overturn an $86 million verdict that found it was responsible for ...
As many as 85,000 glyphosate-cancer lawsuits ‘significantly’ closer to settlement after federal trials suspended
Bayer AG’s federal court cases in the U.S. about the Roundup weedkiller have been pushed back at the request of ...
Technology breeds sustainability on Brazilian family farm
As Brazilian farmer and attorney Henrique Gustavo Fiorese sees it, the future of agriculture depends on technology and sustainability.Though either ...
Dicamba trial: Bayer contends peach farm damage occurred before drift-prone Monsanto herbicide hit the market
In all-day testimony on the eighth day of the trial, [farmer Bill] Bader said as long as dicamba is sprayed ...
With Roundup-cancer settlement looming, activists revive conspiracy claim that glyphosate surfactants threaten human health
The narrative of underdog cancer victims unmasking corporate villains isn't backed up by the evidence ...
Dicamba on trial: Peach farmer testifies Monsanto knew its drift-prone herbicide would damage his 1,000-acre operation
Since 1970, Bill Bader has worked on peach farms in Dunklin County, Missouri, just north of the Arkansas border. Bader ...
Latest Roundup-cancer trial canceled, fueling speculation of a final settlement in glyphosate litigation
A Roundup cancer trial in St. Louis, Missouri, will not open on [Feb. 5] as expected, a court spokesman said ...
